Literature DB >> 808679

Endocrinology and metabolism in uremia and dialysis: a clinical review.

H A Feldman, I Singer.   

Abstract

The salient information regarding the effects of uremia and dialysis on each of the metabolic fuels and hormones presented in the preceding sections is summarized in three tables. Tables 1 and 2 provide data on plasma levels, metabolism, dialysance, and literature references for each substance. Table 3 organizes the data according to the general mechanisms by which uremia and chronic dialysis may affect biological substances. Together these tables provide a reasonably complete summary of the information presently available. The pathophysiology of the uremic syndrome is still incompletely understood. The numerous metabolic and endocrine alterations associated with uremia and chronic dialytic therapy underscore the complexity of the problem and identify several specific areas for future research. One which deserves emphasis is the poolic and endocrine abnormalities found in uremia. A recent review by Chantler and Holliday (63) stressed in the importance of protein-calorie deficiency in the pathogensis of growth retardation and disturbed hormonal metabolism in children with chronic renal failure. The importance of this factor in adult patients with chronic uremia has been less well appreciated. However, striking similarities exist between the metabolic and endocrine abnormalities found in protein-calorie malnutrition and those found in uremia. These include, for example, altered albumin and amino acid metabolism, decreased levels of serum transferrin, peripheral insulin resistance and carbohydrate intolerance, elevated levels of glucagon, cortisol and growth hormone, and possibly diminished secretion of thyrotropin and thyroxine. Although not absolutely identical, the similarities between these two clinical syndromes suggest intriguing possible approaches to a better understanding of the pathophysiology of the uremic syndrome and its treatment.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 808679     DOI: 10.1097/00005792-197509000-00001

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  12 in total

1.  Gastric metaplasia and Campylobacter pylori infection of duodenum in patients with chronic renal failure.

Authors:  S Shousha; C Keen; R A Parkins
Journal:  J Clin Pathol       Date:  1989-04       Impact factor: 3.411

2.  Effect of renal failure on gastrointestinal hormones.

Authors:  J Hansky
Journal:  World J Surg       Date:  1979-08-31       Impact factor: 3.352

3.  Hypothyroidism induced by continuous ambulatory peritoneal dialysis.

Authors:  L A Gavin; N F Eitan; R R Cavalieri; W R Schmidt
Journal:  West J Med       Date:  1983-04

4.  Renal handling of homologous and heterologous insulin in the isolated perfused rat kidney.

Authors:  E Schlatter; H J Schurek; R Zick
Journal:  Pflugers Arch       Date:  1982-05       Impact factor: 3.657

5.  TSH and PRL response to thyrotrophin-releasing hormone in children with chronic renal failure undergoing haemodialysis.

Authors:  K Ijaiya
Journal:  Arch Dis Child       Date:  1979-12       Impact factor: 3.791

6.  The midnight-to-morning urinary cortisol increment method is not reliable for the assessment of hypothalamic-pituitary-adrenal insufficiency in patients with end-stage kidney disease.

Authors:  Y Oguz; C Oktenli; M Ozata; T Ozgurtas; Y Sanisoglu; M Yenicesu; A Vural; F Bulucu; I H Kocar
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

Review 7.  [Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)].

Authors:  W H Hörl; M Hörl; A Heidland
Journal:  Klin Wochenschr       Date:  1982-04-01

8.  Effect of renal failure or portacaval shunt on release of neurotensin in man.

Authors:  E R Eaves; J Hansky
Journal:  Dig Dis Sci       Date:  1987-01       Impact factor: 3.199

9.  Glucagon metabolism in the rat.

Authors:  D S Emmanouel; J B Jaspan; A H Rubenstein; A H Huen; E Fink; A I Katz
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

10.  Lack of dissociation of prolactin responses to thyrotropin releasing hormone and metoclopramide in chronic alcoholic men.

Authors:  D H Van Thiel; J S Gavaler; A Sanghvi
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.